Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based PerspectiveDavid Danielpour
European Journal of Cancer (Oxford, England : 1990)|April 6, 2005
Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostateDavid Danielpour
Cytokine & Growth Factor Reviews|November 22, 2005
Cross-talk between IGF-I and TGF-beta signaling pathwaysDavid Danielpour, Kyung Song
Molecular Cancer Therapeutics|June 21, 2008
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignanciesJorge A Garcia, David Danielpour
The Journal of Biological Chemistry|January 24, 2006
Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type IIKyung Song, Tracy L Krebs, David Danielpour
Cancer Research|March 12, 2009
Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cellsJiayi Yang, Reema Wahdan-Alaswad, David Danielpour
Cancer Research|August 9, 2003
Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type IIKyung Song, Susan C Cornelius, David Danielpour
Current Research in Pharmacology and Drug Discovery|August 22, 2022
Jagged-1 is induced by mTOR inhibitors in renal cancer cells through an Akt/ALK5/Smad4-dependent mechanismDavid Danielpour, Sarah Corum, Patrick Leahy, et al.
The Journal of Biological Chemistry|July 24, 2003
Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2Kyung Song, Susan C Cornelius, Michael Reiss, et al.
Current Research in Pharmacology and Drug Discovery|January 10, 2022
Hypoxia represses early responses of prostate and renal cancer cells to YM155 independent of HIF-1α and HIF-2αDavid Danielpour, Sarah Corum, Scott M Welford, et al.
Pageof 6